Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
n | OR (95% CI) | p value | n | OR (95% CI) | p value | |
Overt DIC | 128 | Â | Â | Â | Â | Â |
 Yes |  | 3.00 (1.40–6.42) | 0.005 |  |  |  |
 No |  | 1.00 (Reference) |  |  |  |  |
Capillary leakage | 128 | Â | Â | 119 | Â | Â |
 Yes |  | 12.00 (2.56–56.36) | 0.002 |  | 6.30 (1.13–35.22) | 0.036 |
 No |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Creatine kinase (IU/L) | 126 | Â | Â | 119 | Â | Â |
  > 500 |  | 7.70 (3.32–17.86) | <0.001 |  | 4.80 (1.86–12.37) | 0.001 |
  ≤ 500 |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Serum sodium (mmol/L) | 128 | Â | Â | 119 | Â | Â |
  < 135 mmol/L |  | 5.35 (2.44–11.74) | <0.001 |  | 4.27 (1.74–10.45) | 0.001 |
  ≥ 135 mmol/L |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Total dose of antivenom (mL) | 121 | Â | Â | Â | Â | Â |
  > 160 |  | 3.01 (1.30–7.00) | 0.010 |  |  |  |
  ≤ 160 |  | 1.00 (Reference) |  |  |  |  |